|
|
|
Insider
Information: |
Winningham Rick E |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,686,408 |
|
Indirect Shares
|
96,467 |
|
|
Direct
Value |
$32,096,465 |
|
|
Indirect Value
|
$926,083 |
|
|
Total
Shares |
2,782,875 |
|
|
Total
Value |
$33,022,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-15.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
130 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2017-06-01 |
4 |
S |
$150.00 |
$750,000 |
D/D |
(5,000) |
10,391 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2017-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,365 |
11,756 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2017-08-11 |
4 |
B |
$24.50 |
$245,000 |
D/D |
10,000 |
866,377 |
2.81 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2017-08-11 |
4 |
S |
$142.36 |
$94,248 |
D/D |
(662) |
11,094 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
894,377 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-02-20 |
4 |
D |
$29.09 |
$378,315 |
D/D |
(13,005) |
881,372 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
987,237 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-05-20 |
4 |
D |
$24.31 |
$1,643,769 |
D/D |
(67,617) |
919,620 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-09 |
4 |
OE |
$46.83 |
$578,655 |
D/D |
9,000 |
20,094 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,495 |
12,589 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-09 |
4 |
S |
$176.03 |
$2,814,838 |
D/D |
(15,979) |
5,610 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2018-08-10 |
4 |
S |
$176.61 |
$116,563 |
D/D |
(660) |
4,950 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-08-20 |
4 |
D |
$26.95 |
$419,261 |
D/D |
(15,557) |
904,063 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2018-11-20 |
4 |
D |
$24.79 |
$385,658 |
D/D |
(15,557) |
795,939 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
317,000 |
1,112,939 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-02-20 |
4 |
D |
$27.00 |
$363,879 |
D/D |
(13,477) |
1,099,462 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-05-20 |
4 |
D |
$19.84 |
$172,172 |
D/D |
(8,678) |
1,091,811 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2019-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
5,150 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2019-08-09 |
4 |
S |
$135.65 |
$98,482 |
D/D |
(726) |
4,424 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-08-20 |
4 |
D |
$21.51 |
$186,664 |
D/D |
(8,678) |
1,083,133 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2019-11-20 |
4 |
D |
$17.60 |
$152,733 |
D/D |
(8,678) |
1,074,455 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
338,000 |
1,412,455 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-02-20 |
4 |
D |
$25.90 |
$2,508,415 |
D/D |
(96,850) |
1,315,605 |
0 |
- |
|
TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
|
2020-05-20 |
4 |
D |
$26.67 |
$371,940 |
D/D |
(13,946) |
1,303,061 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2020-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,705 |
7,129 |
0 |
- |
|
130 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|